Therefore, in general, an upregulation of the pro-survival Bcl-xL is often observed in cancer cells, which may be, at least in part, due to the dysregulation of certain splice factors involved in Bcl-x pre-mRNA splicing. The gene discussed is BCL2L1; the disease is cancer.